Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Combination Product: mavrilimumab[1] Mavrilimumab (Mavrilimumab)[1] Mavrilimumab (Mavrilimumab) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 41 💬
2MAVRILIMUMAB[1] Mavrilimumab (Mavrilimumab)[1] Mavrilimumab (Mavrilimumab) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[2] 41, 46 💬
3Mavrilimumab 10 mg[1] Mavrilimumab (Mavrilimumab)[1] Mavrilimumab (Mavrilimumab) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46 💬
4Mavrilimumab 100 mg[1] Mavrilimumab (Mavrilimumab)[1] Mavrilimumab (Mavrilimumab) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46 💬
5Mavrilimumab 150 mg[1] Mavrilimumab (Mavrilimumab)[1] Mavrilimumab (Mavrilimumab) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46 💬
6Mavrilimumab 30 mg[1] Mavrilimumab (Mavrilimumab)[1] Mavrilimumab (Mavrilimumab) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46 💬
7Mavrilimumab 50 mg[1] Mavrilimumab (Mavrilimumab)[1] Mavrilimumab (Mavrilimumab) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46 💬